2. DEFINITION OF
DEFINITION OF
GLOMERULONEPHRITIS
GLOMERULONEPHRITIS
Most important group of
generalized parenchimal
diseases of mainly autoimmune
origin which has similar:
Etiology and pathogenesis
Etiology and pathogenesis
Clinical features
Clinical features
Morphology (various histology
Morphology (various histology
patterns)
patterns)
3. MAJOR CLINICAL MANIFESTATIONS OF
MAJOR CLINICAL MANIFESTATIONS OF
GLOMERULONEPHRITIS
GLOMERULONEPHRITIS
Acute nephritic syndrome
Nephrotic syndrome
Persistent urinary abnormalities with few or no
symptoms
Chronic glomerulonephritis
8. Features of acute nephritic syndrome
Features of acute nephritic syndrome
Haematuria is usually macroscopic with pink or
brown urine (like coca-cola)
Oliguria may be overlooked or absent in milder
cases
Oedema is usually mild or is often just peri-orbital-
weight gain may be detected
Hypertension common and associated with raised
urea and creatinine
Proteinuria is variable but usually less than in the
nephrotic syndrome
9. MANAGEMENT ISSUES IN THE NEPHRITIC
MANAGEMENT ISSUES IN THE NEPHRITIC
SYNDROME
SYNDROME
Skin and throat swab
Strep serology
Evaluation of complement
Urea, creatinine, electrolytes, urinalysis
BP
Urine output and daily weight loss
Fluid and diet management
Treatment of infections
10. COMLICATIONS OF NEPHRITIC SYNDROME
COMLICATIONS OF NEPHRITIC SYNDROME
Hypertensive encephalopathy
(seizures, coma)
Heart failures (pulmonary oedema)
Uraemia requiring hemodialysis
11. NEPHROTIC SYNDROME
NEPHROTIC SYNDROME
This is a group of signs and symptoms
seen in patients with heavy proteinuria
Clinical features:
Clinical features:
Oedema
Proteinuria >3,5 g/24 hrs (> 0,05 g/kg/24
hrs)
Serum albumen <30 g/l
Hyperlipidemia and hypercoagulable
state
12. Primary glomerular diseases causing
Primary glomerular diseases causing
the nephrotic syndrome
the nephrotic syndrome
o Minimal change disease
Minimal change disease
o Focal and segmental glomerulosclerosis
Focal and segmental glomerulosclerosis
o Membranous glomerulonephritis
Membranous glomerulonephritis
o Proliferative nephritis:
Proliferative nephritis:
o Membrano-proliferative
Membrano-proliferative
Focal proliferative
Focal proliferative
Diffuse proliferative
Diffuse proliferative
Mesangial proliferative
Mesangial proliferative
16. MANAGEMENT OF PATIENTS WITH
MANAGEMENT OF PATIENTS WITH
NEPHROTIC SYNDROME
NEPHROTIC SYNDROME
Na+ <60 mmol/24 hrs
Water restriction
Diuretics (if no volume depleted)
Reduced protein diet (controversial!!!)
Treatment of infections
Prevention of thrombosis
Specific therapy: corticosteroids,
immunosupression
For minimal change disease: prednisone for
prednisone for
16 weeks or prednisone+cyclophosphamide!!!
16 weeks or prednisone+cyclophosphamide!!!
17. INDICATIONS FOR HEMODIALYSIS
INDICATIONS FOR HEMODIALYSIS
• Pericarditis or pleuritis (urgent indication)
• Progressive uremic encephalopathy or neuropathy,
with signs such as confusion, asterixis, myoclonus,
wrist or foot drop, or, in severe cases, seizures
(urgent indication)
• A clinically significant bleeding diathesis attributable
to uremia (urgent indication)
• Fluid overload refractory to diuretics
• Hypertension poorly responsive to antihypertensive
medications
• Persistent metabolic disturbances that are refractory
to medical therapy; these include hyperkalemia,
metabolic acidosis, hypercalcemia, hypocalcemia,
and hyperphosphatemia
• Persistent nausea and vomiting
• Evidence of malnutrition